Literature DB >> 29702018

Percutaneous Ablation for Hepatocellular Carcinoma.

Jeffrey L Weinstein1, Muneeb Ahmed1.   

Abstract

OBJECTIVE: The purpose of this article is to discuss the use, comparative efficacy, and general technical considerations of percutaneous ablation, alone or in combination with other therapies, for the treatment of hepatocellular carcinoma (HCC).
CONCLUSION: Percutaneous ablation is a mainstay treatment for early-stage HCC, offering survival comparable to that of surgical resection for small lesions. It can act as a primary curative therapy or bridge therapy for patients waiting to undergo liver transplant. New ablation modalities and combining tumor ablation with other therapies, such as transarterial chemoembolization, can improve clinical outcomes and allow treatment of larger lesions. Combining thermal ablation with systemic chemotherapy, including immunotherapy, is an area of future development.

Entities:  

Keywords:  ablation; hepatocellular carcinoma; percutaneous; radiofrequency

Mesh:

Year:  2018        PMID: 29702018     DOI: 10.2214/AJR.17.18695

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  6 in total

Review 1.  Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation-part one: curative intention.

Authors:  Joseph H Yacoub; Christine C Hsu; Thomas M Fishbein; David Mauro; Andrew Moon; Aiwu R He; Mustafa R Bashir; Lauren M B Burke
Journal:  Abdom Radiol (NY)       Date:  2021-04-09

2.  Local-Regional Treatment of Hepatocellular Carcinoma: A Primer for Radiologists.

Authors:  Natally Horvat; Ana I de Oliveira; Brunna Clemente de Oliveira; Jose A B Araujo-Filho; Maria El Homsi; Ahmed Elsakka; Raazi Bajwa; Guilherme L P Martins; Khaled M Elsayes; Marcos R Menezes
Journal:  Radiographics       Date:  2022-10       Impact factor: 6.312

3.  F-18 FDG perfusion PET: intraprocedural assessment of the liver tumor ablation margin.

Authors:  Paul B Shyn; Alan J Cubre; Paul J Catalano; Leslie K Lee; Hyewon Hyun; Kemal Tuncali; Julia G Seol; Vincent M Levesque; Victor H Gerbaudo; Tina Kapur; Ryan T Chao; Stuart G Silverman
Journal:  Abdom Radiol (NY)       Date:  2021-02-19

4.  Safety and effectiveness of multi-antenna microwave ablation-oriented combined therapy for large hepatocellular carcinoma.

Authors:  Tian-Qi Zhang; Zhi-Mei Huang; Jing-Xian Shen; Gui-Qun Chen; Lu-Jun Shen; Fei Ai; Yang-Kui Gu; Wang Yao; Yan-Yang Zhang; Rong-Ping Guo; Min-Shan Chen; Jin-Hua Huang
Journal:  Therap Adv Gastroenterol       Date:  2019-08-21       Impact factor: 4.409

5.  Efficacy and Safety of Fusion Imaging in Radiofrequency Ablation of Hepatocellular Carcinoma Compared to Ultrasound: A Meta-Analysis.

Authors:  Tao Jie; Feng Guoying; Tang Gang; Shi Zhengrong; Li Maoping
Journal:  Front Surg       Date:  2021-12-06

Review 6.  Efficacy and safety of various primary treatment strategies for very early and early hepatocellular carcinoma: a network meta-analysis.

Authors:  Sha Yang; Huapeng Lin; Jianning Song
Journal:  Cancer Cell Int       Date:  2021-12-19       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.